标题
Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-05-16
DOI
10.3389/fimmu.2018.01087
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IL-10-Engineered Human CD4 + Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
- (2017) Grazia Locafaro et al. MOLECULAR THERAPY
- Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
- (2017) Arjang Baygan et al. Frontiers in Immunology
- Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia Activity
- (2016) Shuting Zhao et al. ACS Nano
- Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease
- (2016) Lenneke F.J. van Groningen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells
- (2016) M. Leclerc et al. BLOOD
- Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
- (2016) M. Mielcarek et al. BLOOD
- Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
- (2016) R. Flynn et al. BLOOD
- Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses
- (2016) Yusuke Shono et al. CANCER RESEARCH
- Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation
- (2016) Toshihiro Miyamoto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
- (2016) Enrico Maffini et al. Journal of Hematology & Oncology
- Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update
- (2015) W Arcese et al. BONE MARROW TRANSPLANTATION
- Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models
- (2015) Dan Yang et al. CELL TRANSPLANTATION
- Generation of Human Alloantigen-Specific Regulatory T Cells under Good Manufacturing Practice-Compliant Conditions for Cell Therapy
- (2015) Mustapha Chera et al. CELL TRANSPLANTATION
- Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study
- (2015) Kazuo Muroi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Cellular and molecular mechanisms in graft-versus-host disease
- (2015) Lingling Zhang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
- (2015) R Zeiser et al. LEUKEMIA
- Imatinib for sclerodermatous graft-versus-host disease in lung transplantation
- (2015) Jitian Zhang et al. Interactive Cardiovascular and Thoracic Surgery
- Clinical Outlook for Type-1 and FOXP3+ T Regulatory Cell-Based Therapy
- (2015) Silvia Gregori et al. Frontiers in Immunology
- Administration of Anti-CD20 mAb Is Highly Effective in Preventing but Ineffective in Treating Chronic Graft-Versus-Host Disease While Preserving Strong Graft-Versus-Leukemia Effects
- (2014) Heather F. Johnston et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
- (2014) Erin Gatza et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Therapeutic activity of multiple common -chain cytokine inhibition in acute and chronic GVHD
- (2014) A.-K. Hechinger et al. BLOOD
- HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
- (2014) M. F. Martelli et al. BLOOD
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent
- (2014) J J Scarisbrick et al. BONE MARROW TRANSPLANTATION
- Mesenchymal stem cells suppress CD8+T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-β
- (2014) Mingfen Li et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
- (2014) A. A. Kennedy-Nasser et al. CLINICAL CANCER RESEARCH
- Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols
- (2014) C. Capelli et al. HAEMATOLOGICA
- PIAS3 suppresses acute graft- versus -host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation
- (2014) Sung-Hee Lee et al. IMMUNOLOGY LETTERS
- Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease
- (2014) Doanh Le Huu et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- A Small-Molecule c-Rel Inhibitor Reduces Alloactivation of T Cells without Compromising Antitumor Activity
- (2014) Y. Shono et al. Cancer Discovery
- Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
- (2014) Joo Han Park et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice
- (2013) Nayoun Kim et al. ANNALS OF HEMATOLOGY
- Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells
- (2013) Piotr Trzonkowski et al. BIODRUGS
- Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients
- (2013) Martino Introna et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease
- (2013) J. M. Coghill et al. BLOOD
- Anionic carbohydrate-containing chitosan scaffolds for bone regeneration
- (2013) Hyejin Park et al. CARBOHYDRATE POLYMERS
- Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints
- (2013) Lisbeth Barkholt et al. CYTOTHERAPY
- Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease
- (2013) Esma S. Yolcu et al. EXPERIMENTAL HEMATOLOGY
- Advances in the treatment of acute graft-versus-host disease
- (2013) Liren Qian et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Blockade of individual Notch ligands and receptors controls graft-versus-host disease
- (2013) Ivy T. Tran et al. JOURNAL OF CLINICAL INVESTIGATION
- T Cell-Specific Notch Inhibition Blocks Graft-versus-Host Disease by Inducing a Hyporesponsive Program in Alloreactive CD4+ and CD8+ T Cells
- (2013) A. R. Sandy et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Receptors for C3a and C5a Modulate Stability of Alloantigen-Reactive Induced Regulatory T Cells
- (2013) W. van der Touw et al. JOURNAL OF IMMUNOLOGY
- Third-party Tolerogenic Dendritic Cells Reduce Allo-reactivityIn vitroand Ameliorate the Severity of Acute graft-Versus-host Disease in Allo-bone Marrow Transplantation
- (2013) J. Yang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Human CD8+ Regulatory T Cells Inhibit GVHD and Preserve General Immunity in Humanized Mice
- (2013) J. Zheng et al. Science Translational Medicine
- Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease
- (2013) Muriel Hannon et al. TRANSFUSION
- Targeting CD83 for the treatment of graft-versus-host disease
- (2013) XIONGFEI WANG et al. Experimental and Therapeutic Medicine
- Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro
- (2013) Cristina Nazarov et al. Stem Cell Research & Therapy
- Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL
- (2013) M. R. Verneris Hematology-American Society of Hematology Education Program
- Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody
- (2012) N. Poirier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes
- (2012) Sung W. Choi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
- (2012) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Promoting transplantation tolerance; adoptive regulatory T cell therapy
- (2012) N. Safinia et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Human mesenchymal stem cells suppress donor CD4+T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease
- (2012) L. M. Tobin et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Long-term follow-up of children treated with daclizumab for steroid-refractory gastrointestinal GvHD in a prospective study
- (2012) Amir Ali Hamidieh et al. PEDIATRIC TRANSPLANTATION
- Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
- (2012) Jun Yang et al. PEDIATRIC TRANSPLANTATION
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
- (2012) Manoj M. Lalu et al. PLoS One
- Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
- (2012) Aurélie Moreau et al. Frontiers in Immunology
- Cell Therapy With Autologous Tolerogenic Dendritic Cells Induces Allograft Tolerance Through Interferon-Gamma and Epstein-Barr Virus-Induced Gene 3
- (2011) M. Hill et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prophylactic Effects of Interleukin-2 Receptor Antagonists against Graft-versus-Host Disease Following Unrelated Donor Peripheral Blood Stem Cell Transplantation
- (2011) Jun Fang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- T-cell depletion in GVHD: less is more?
- (2011) J. H. Antin BLOOD
- Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17
- (2011) H. Nishimori et al. BLOOD
- Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
- (2011) H.-J. Shin et al. BLOOD
- The use of monoclonal antibodies for the treatment of graft-versus-host disease following allogeneic stem cell transplantation
- (2011) Alessandro Busca EXPERT OPINION ON BIOLOGICAL THERAPY
- Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?
- (2011) Nathalie Cools et al. Immunotherapy
- Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without Abrogating the Graft-versus-Leukemia Effect in Murine Models
- (2010) Omar Duramad et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
- (2010) A Rager et al. BONE MARROW TRANSPLANTATION
- Negative vaccination by tolerogenic dendritic cells in organ transplantation
- (2010) Marcelo Hill et al. Current Opinion in Organ Transplantation
- Development of Dendritic Cell-Based Immunotherapy for Autoimmunity
- (2010) Catharien M. U. Hilkens et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase
- (2010) Zhu Lan et al. TRANSPLANTATION
- Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection
- (2010) Wei Ge et al. TRANSPLANTATION
- A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease
- (2009) Daniel R. Couriel et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis
- (2009) Mohamed A. Kharfan-Dabaja et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
- (2009) John Wilson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Improved Survival and Preserved Antiviral Responses After Combination Therapy With Daclizumab and Infliximab in Steroid-refractory Graft-Versus-Host Disease
- (2009) Kanchan Rao et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience
- (2008) M Miano et al. BONE MARROW TRANSPLANTATION
- Dendritic cell CD83: A therapeutic target or innocent bystander?
- (2007) Charlene M. Prazma et al. IMMUNOLOGY LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now